{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:30:11Z","timestamp":1790728211468,"version":"4.1.0"},"reference-count":70,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Cardiovascular disease remains the leading cause of premature mortality worldwide. Subclinical glucose dysregulation, a contributor to accelerated vascular aging, is undetectable by conventional screening in apparently healthy individuals; even within the normal glycemic range, postprandial glucose excursions promote endothelial injury and inflammatory pathways independently of mean glucose levels. Hypothesis: Continuous glucose monitoring (CGM)-guided metabolic phenotyping, combined with personalized dietary optimization, structured fasting protocols, and selective longevity-oriented pharmacotherapy, constitutes a mechanistically coherent, hypothesis-generating preventive strategy that may attenuate cardiovascular risk and biological aging in apparently healthy non-diabetic adults, pending confirmation in prospective outcome trials. Materials and Methods: This narrative review synthesizes evidence from prospective cohort studies, randomized controlled trials, and mechanistic investigations connecting CGM-guided metabolic assessment with preventive cardiology and the emerging field of longevity medicine, focusing on glycemic variability biology, nutrient-sensing pathways, and the cardiovascular and longevity profiles of low-dose metformin and acarbose. Results: CGM-derived metrics capture inter-individual glycemic variability invisible to standard assessments and provide behavioral feedback for dietary personalization. Structured fasting and low-dose metformin converge on shared nutrient-sensing pathways implicated in both vascular aging and longevity, with CGM enabling objective confirmation of metabolic adaptation. Acarbose has shown cardiovascular and lifespan benefit signals in secondary trial analyses and preclinical longevity models, though these findings require replication and are not yet established in non-diabetic populations. Conclusions: We propose a four-phase research framework integrating CGM metabolic phenotyping, dietary optimization, fasting titration, and selective pharmacological augmentation for apparently healthy adults at cardiovascular risk. Prospective hard-endpoint trials are lacking, and this framework should be regarded as hypothesis-generating rather than an established clinical strategy, warranting rigorous outcome-based evaluation before clinical adoption.<\/jats:p>","DOI":"10.3390\/medicina62081513","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:46:38Z","timestamp":1786009598000},"page":"1513","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond Diabetes: Continuous Glucose Monitoring as a Candidate Precision Tool for Cardiovascular Prevention and Healthy Longevity\u2014A Hypothesis-Generating Narrative Review"],"prefix":"10.3390","volume":"62","author":[{"given":"Cristina","family":"V\u0103c\u0103rescu","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Diseases Timisoara, 300310 Timisoara, Romania"},{"name":"Cardiology Department, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"},{"name":"Research Center of the Institute of Cardiovascular Diseases Timisoara, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7378-7787","authenticated-orcid":false,"given":"Dragos","family":"Cozma","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Diseases Timisoara, 300310 Timisoara, Romania"},{"name":"Cardiology Department, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"},{"name":"Research Center of the Institute of Cardiovascular Diseases Timisoara, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: Cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: Clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized Nutrition by Prediction of Glycemic Responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"Blasco","year":"2023","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of Intermittent Fasting on Health, Aging, and Disease","volume":"381","author":"Mattson","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.53.3.701","article-title":"Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment","volume":"53","author":"Ceriello","year":"2004","journal-title":"Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Singh, J., Owusu Konadu, A.S., Li, Y., and Li, Y.L. (2026). Impact of PKC-MAPK Signaling on Cardiac Sympathetic Overactivation in Type-2 Diabetes Mellitus. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27020723"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.2337\/dc10-2414","article-title":"Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: Lessons from the San Luigi Gonzaga Diabetes Study","volume":"34","author":"Cavalot","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF00400637","article-title":"The Verona diabetes study: A population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality","volume":"38","author":"Muggeo","year":"1995","journal-title":"Diabetologia"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wilczek, F., van der Stouwe, J.G., Petrasch, G., and Niederseer, D. (2025). Non-Invasive Continuous Glucose Monitoring in Patients Without Diabetes: Use in Cardiovascular Prevention-A Systematic Review. Sensors, 25.","DOI":"10.3390\/s25010187"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1089\/dia.2017.0035","article-title":"Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes","volume":"19","author":"Rodbard","year":"2017","journal-title":"Diabetes Technol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/diagnostics3040385","article-title":"Continuous Glucose Monitoring Systems: A Review","volume":"3","author":"Vashist","year":"2013","journal-title":"Diagnostics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12020-019-02150-1","article-title":"Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: A meta-analysis","volume":"67","author":"Pu","year":"2020","journal-title":"Endocrine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/oby.2005.61","article-title":"Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting","volume":"13","author":"Heilbronn","year":"2005","journal-title":"Obes. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cmet.2018.04.010","article-title":"Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes","volume":"27","author":"Sutton","year":"2018","journal-title":"Cell Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1748-4","article-title":"Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: A systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Cioffi","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: Molecular mechanisms and clinical applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1172539","article-title":"Extending healthy life span\u2014From yeast to humans","volume":"328","author":"Fontana","year":"2010","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2014.08.009","article-title":"\u0392-hydroxybutyrate: Much more than a metabolite","volume":"106","author":"Newman","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jn\/116.4.641","article-title":"The retardation of aging in mice by dietary restriction: Longevity, cancer, immunity and lifetime energy intake","volume":"116","author":"Weindruch","year":"1986","journal-title":"J. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S2213-8587(19)30151-2","article-title":"2 years of calorie restriction and cardiometabolic risk (CALERIE): Exploratory outcomes of a multicentre, phase 2, randomised controlled trial","volume":"7","author":"Kraus","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"201149","DOI":"10.1016\/j.humgen.2023.201149","article-title":"Impact of probiotics in alleviating type 2 diabetes risk in clinical trials: A meta-analysis study","volume":"35","author":"Singh","year":"2023","journal-title":"Hum. Gene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/clinem\/dgad639","article-title":"Lifestyle Intervention with Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial","volume":"109","author":"Kitazawa","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.2337\/dc15-0429","article-title":"Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels","volume":"38","author":"Shukla","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1249\/MSS.0b013e3181b3b16d","article-title":"Low-intensity exercise reduces the prevalence of hyperglycemia in type 2 diabetes","volume":"42","author":"Manders","year":"2010","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"E1402","DOI":"10.1073\/pnas.1516953113","article-title":"Circadian misalignment increases cardiovascular disease risk factors in humans","volume":"113","author":"Morris","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1177\/19322968221110830","article-title":"Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come?","volume":"17","author":"Klonoff","year":"2023","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/dc12-0963","article-title":"Resistance versus aerobic exercise: Acute effects on glycemia in type 1 diabetes","volume":"36","author":"Yardley","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40279-023-01910-4","article-title":"Continuous Glucose Monitoring in Endurance Athletes: Interpretation and Relevance of Measurements for Improving Performance and Health","volume":"54","author":"Flockhart","year":"2024","journal-title":"Sports Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.00038.2012","article-title":"Exercise, GLUT4, and skeletal muscle glucose uptake","volume":"93","author":"Richter","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/dom.12354","article-title":"Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls","volume":"16","author":"Bannister","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a Tool to Target Aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Mercken","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"928","DOI":"10.7326\/0003-4819-121-12-199412150-00004","article-title":"The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial","volume":"121","author":"Chiasson","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/acel.12170","article-title":"Acarbose, 17-\u03b1-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males","volume":"13","author":"Harrison","year":"2014","journal-title":"Aging Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cmet.2016.05.014","article-title":"The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research","volume":"23","author":"Milman","year":"2016","journal-title":"Cell Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-8587(17)30309-1","article-title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): A randomised, double-blind, placebo-controlled trial","volume":"5","author":"Holman","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00125-003-1318-y","article-title":"Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data","volume":"47","author":"Kaiser","year":"2004","journal-title":"Diabetologia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0195-668X(03)00468-8","article-title":"Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies","volume":"25","author":"Hanefeld","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12966-024-01622-6","article-title":"Leveraging continuous glucose monitoring as a catalyst for behaviour change: A scoping review","volume":"21","author":"Jospe","year":"2024","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Domaszewski, P., Rogowska, A.M., and \u017bylak, K. (2024). Examining Associations Between Fasting Behavior, Orthorexia Nervosa, and Eating Disorders. Nutrients, 16.","DOI":"10.3390\/nu16244275"},{"key":"ref_52","first-page":"e94460","article-title":"Use of Continuous Glucose Monitoring in Non-diabetic Individuals for Cardiovascular Prevention: A Systematic Review of Its Impact on Guiding Lifestyle Interventions","volume":"17","author":"Ahmed","year":"2025","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e80734","DOI":"10.2196\/80734","article-title":"Continuous Glucose Monitoring for Personalized Nutrition in Real-World Vively App Users: Retrospective Observational Study","volume":"13","author":"Jospe","year":"2026","journal-title":"JMIR Hum. Factors"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12966-025-01870-0","article-title":"Effects of continuous glucose monitoring on physical activity and diet in diabetes: A systematic review and meta-analysis","volume":"23","author":"Peng","year":"2026","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cod.14698","article-title":"Allergic contact dermatitis caused by glucose sensors and insulin pumps: A full review: Part 1: Sensors and pumps, adverse cutaneous reactions, allergens, and diabetes devices causing allergic contact dermatitis","volume":"92","author":"Ipenburg","year":"2025","journal-title":"Contact Dermat."},{"key":"ref_56","unstructured":"GoodRx Health (2026, August 03). How Much Does a Continuous Glucose Monitor Cost?. Available online: https:\/\/www.goodrx.com\/conditions\/diabetes\/continuous-glucose-monitor-cost."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40842-023-00152-7","article-title":"Intermittent fasting: Consider the risks of disordered eating for your patient","volume":"9","author":"Blumberg","year":"2023","journal-title":"Clin. Diabetes Endocrinol."},{"key":"ref_58","unstructured":"Persaud-Sharma, D., Saha, S., and Trippensee, A.W. (2026, August 03). Refeeding Syndrome, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564513\/."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Herman, R., Trsan, J., Lipar, L., Jensterle, M., and Janez, A. (2025). Endocrine Adaptations to Prolonged Fasting: From Physiology, Clinical Uncertainties, Translational Challenges to Healthspan Implications. Nutrients, 17.","DOI":"10.3390\/nu17243949"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4093\/dmj.2020.0004","article-title":"Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement","volume":"44","author":"Hur","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: A retrospective cohort study","volume":"37","author":"Richy","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_62","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"2017","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"c2181","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomised placebo controlled trial","volume":"340","author":"Kooy","year":"2010","journal-title":"BMJ"},{"key":"ref_64","unstructured":"U.S. Food and Drug Administration (2026, August 03). Precose (Acarbose) Tablets: Prescribing Information, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020482s025lbl.pdf."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2337\/diacare.28.1.154","article-title":"Alpha-glucosidase inhibitors for patients with type 2 diabetes: Results from a Cochrane systematic review and meta-analysis","volume":"28","author":"Lucassen","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Juliana, N., Zulkefly, M.I.H., Maluin, S.M., Halim, H.A., Roslly, M.Z., Ithnin, M., Fuad, S.H., Hamid, N.A., and Azmani, S. (2026). Validation and diagnostic accuracy of a multi-frequency bioelectrical impedance analysis device with dual-energy X-ray absorptiometry (DXA) for estimating body composition among healthy Malaysian adults. Front. Anal. Sci., 6.","DOI":"10.3389\/frans.2026.1767078"},{"key":"ref_67","first-page":"7","article-title":"Implementing Continuous Glucose Monitoring in Clinical Practice","volume":"28","author":"Adkison","year":"2021","journal-title":"Fam. Pract. Manag."},{"key":"ref_68","first-page":"1","article-title":"Mechanistic Pathways of Sex Differences in Cardiovascular Disease","volume":"97","author":"Kararigas","year":"2017","journal-title":"Physiol. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ilias, I., Rizzo, M., and Zabuliene, L. (2022). Metformin: Sex\/Gender Differences in Its Uses and Effects\u2014Narrative Review. Medicina, 58.","DOI":"10.3390\/medicina58030430"},{"key":"ref_70","first-page":"5527973","article-title":"Classic and Novel Sex Hormone Binding Globulin Effects on the Cardiovascular System in Men","volume":"2021","author":"Llanos","year":"2021","journal-title":"Int. J. Endocrinol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1513\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:29:50Z","timestamp":1786012190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081513"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081513","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}